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The mechanisms for early initiation of
LPS-induced acute lung injury are not
well understood. Arditi and colleagues
show that LPS initiates pulmonary
inflammation by inducing necrosis in
alveolar macrophages via aCD14-P2x7R-
Ca2+ pathway. Necrosis leads to pro-IL-
1a release and subsequent EC activation
allowing neutrophil recruitment into the
lungs.
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Acute lung injury (ALI) remains a serious health issue
with little improvement in our understanding of the
pathophysiology and therapeutic approaches. We
investigated the mechanism that lipopolysaccharide
(LPS) induces early neutrophil recruitment to lungs
and increases pulmonary vascular permeability
during ALI. Intratracheal LPS induced release of
pro-interleukin-1a (IL-1a) from necrotic alveolar
macrophages (AM), which activated endothelial cells
(EC) to induce vascular leakage via loss of vascular
endothelial (VE)-cadherin. LPS triggered the AM
purinergic receptor P2X7(R) to induce Ca2+ influx
and ATP depletion, which led to necrosis. P2X7R
deficiency significantly reduced necrotic death of
AM and release of pro-IL-1a into the lung. CD14
was required for LPS binding to P2X7R, as CD14
neutralization significantly diminished LPS induced
necrotic death of AM and pro-IL-1a release. These
results demonstrate a key role for pro-IL-1a from
necrotic alveolar macrophages in LPS-mediated
ALI, as a critical initiator of increased vascular
permeability and early neutrophil infiltration.
INTRODUCTION
Acute respiratory distress syndrome (ARDS) is a life-threatening
condition of acute lung injury (ALI) characterized by bilateral
pulmonary infiltrates, severe hypoxemia, and non-cardiogenic
pulmonary edema (Matthay et al., 2012). Despite decades of
research and numerous clinical trials, the only treatment that
reduces mortality in ARDS is mechanical ventilation using low
tidal volumes (Matthay et al., 2003). Even with best supportive
care, the mortality from ARDS approaches 30%–50% (Matthay
et al., 2012), emphasizing the need for better understanding of
the pathophysiology and new treatments.
Lipopolysaccharide (LPS)-induced ALI is an animal model that
replicates several key pathologic processes of ARDS, including640 Immunity 42, 640–653, April 21, 2015 ª2015 Elsevier Inc.loss of vascular integrity, neutrophil infiltration, and accumula-
tion of protein-rich fluid in the airspaces of the lung (Matute-Bello
et al., 2011; Orfanos et al., 2004; Tsushima et al., 2009). There is
great interest in the mechanisms by which LPS disrupts the
endothelial barrier to allow increased lung vascular permeability
and alveolar edema. Multiple mechanisms have been postu-
lated, including decreased intracellular cAMP concentrations
(Schlegel et al., 2009), modulation of atrial natriuretic peptide
receptors (Xing et al., 2012), induction of sphingosine-1-phos-
phatase (Zhao et al., 2011), and stimulation of RhoA-Rho kinase
pathway (Han et al., 2013), among others. However, while exper-
imental evidence indicates that LPS administered to the lung
does not signal through Toll-like receptor-4 (TLR4) on the
endothelium but instead targets hematopoietic and epithelial
cells (Andonegui et al., 2009), it remains uncertain as to which
secondary mediators, such as tumor necrosis factor-a (TNF-a),
interleukin-1b (IL-1b), and other cytokines released from
macrophages and/or damaged epithelium, provide the neces-
sary signals on the endothelium for vascular dysfunction and
neutrophil influx (Salgado et al., 1994).
Interleukin-1 (IL-1) is a master cytokine of local and systemic
inflammation, and the IL-1 family of ligands and receptors is
associated with both acute and chronic inflammation induced
by bacteria and bacterial products (Dinarello, 2011; Ulich et al.,
1991a; Ulich et al., 1991b). There are two related but distinct
IL-1 genes, Il1a and Il1b, encoding IL-1a and IL-1b, respectively
(Dinarello, 2011). Both IL-1a and IL-1b bind to the same cell sur-
face receptor, IL-1R1, which is present on nearly all cells. While
the role of IL-1a in innate immune responses has been reported
for Legionella pneumophila (Barry et al., 2013), the role and the
mechanism of IL-1a-dependent neutrophil recruitment in vivo
in LPS-induced acute lung injury has not been investigated.
The ‘‘danger’’ model proposes that the immune system re-
sponds to nonphysiological cell death, damage, or stress (Mat-
zinger, 1994). Accordingly, necrotic cell death releases dam-
age-associated molecular patterns (DAMPs), which activate
immune pathways (Chen et al., 2007; Chen and Nun˜ez, 2010; Ei-
genbrod et al., 2008). Because IL-1a can be released by necrotic
cells to induce sterile inflammation, it can be considered to func-
tion as a DAMP under these circumstances (Chen and Nun˜ez,
2010).
Endothelial cells are critical mediators of the inflammatory
response (Pober and Sessa, 2007). However, the importance
of endothelium in innate immunity, specifically as it pertains
to LPS-induced ALI and neutrophil recruitment, still remains
underappreciated. Adherens junction proteins such as VE-
cadherin are critically involved in controlling vascular perme-
ability (Dejana et al., 2008), and IL-1b can disrupt VE-cadherin
cell-surface localization by promoting its endocytic internali-
zation (London et al., 2010). Mice expressing TLR4 only on
their endothelium do not accumulate neutrophils in the lungs
following intratracheal administration of LPS, indicating that,
at least for LPS-TLR4 signaling, TLR4 is required on bone-
marrow-derived leukocytes (Andonegui et al., 2009). Addition-
ally, MyD88 adaptor-based signaling in endothelial cells is
important for the disruption of endothelial barrier function and
vascular permeability (Zhu et al., 2012).
While LPS induces pro-inflammatory signals through TLR4,
the P2X7 receptor also can bind bacterial LPS (Denlinger et al.,
2001). P2X7 receptors are a family of ATP gated ion channels
that make the plasma membrane permeable to small cations
such as Ca2+, resulting in cellular depolarization (Costa-Junior
et al., 2011), and they have gained recent attention due to their
ability to induce Ca2+ mobility (Garcia-Marcos et al., 2006).
P2X7R is expressed in most immune cells (Volonte´ et al.,
2012), and its expression rapidly increases in alveolar macro-
phages (AMs) following smoke-induced lung inflammation
(Lucattelli et al., 2011). Moreover, P2X7R may function in the
pathophysiology of LPS-induced ALI (Monc¸a˜o-Ribeiro et al.,
2011). Indeed, P2X7 receptor-deficient mice show reduced
inflammation and lung fibrosis to bleomycin injury (Mishra, 2013).
In our study of LPS-induced ALI, we found that LPS adminis-
tered intratracheally led to increased Ca2+ influx via a CD14-
P2X7R dependent pathway in AMs, which resulted in ATP
depletion followed by necrotic death of the AMs. AM necrosis
led to the release of pro-IL-1a into the alveolar space, which
in turn induced vascular leakage through endothelial IL-1R
signaling. Our results reveal a key role for pro-IL-1a released
from necrotic alveolar macrophages in LPS-induced ALI as
a critical initiator of increased vascular permeability and early
neutrophil infiltration.
RESULTS
Necrotic Alveolar Macrophages Release IL-1a
in LPS-induced ALI
LPS instilled intratracheally (i.t.) induces neutrophil recruitment
and vascular leakage into the lungs, but the exact mechanism
controlling these responses is unknown. AMs play a major role
in LPS-induced neutrophil (PMN) accumulation in the lungs
(Harmsen, 1988). AM numbers decreased 4 hr after LPS instilla-
tion, whereas PMN numbers increased over time in the bronchi-
olar lavage fluid (BALF) (Figure 1A). Thus, we hypothesized
that dying AMs might trigger neutrophil infiltration into the
lung by releasing IL-1b and IL-1a. Secretion of both IL-1b and
IL-1a is impaired in macrophages from Casp1/ or Nlrp3/
mice (Gross et al., 2012). Therefore, we assessed whether
the inflammasome was involved in ALI by using Casp1/ or
Nlrp3/ mice. WT, Nlrp3/, and Casp1/ mice were given
LPS (i.t.) and 6 hr later myeloperoxidase (MPO) activity, asurrogate of PMN numbers, was measured. MPO activity did
notdiffer amongWT,Casp1/, orNlrp3/mice (Figure1B), sug-
gesting that the inflammasome did not play a role in LPS-induced
ALI in this model. Furthermore, we measured the concentrations
of IL-1b, IL-1a, and KC chemokine in BALF and lung homoge-
nates. Corroborating our data that the inflammasome was not
involved in LPS induced ALI, IL-1b protein was only detected in
the lung homogenate and its concentration was not altered in
Nlrp3/ and Casp1/ mice (Figure 1C). In contrast, both IL-1a
and KC were significantly increased in BALF and lung homo-
genates of LPS-treated mice but again, these endpoints did not
differ among genotypes (Figures 1D and 1E).
Previous studies found that pro-IL-1a can be released
passively via necrosis from dying macrophages and trigger
sterile inflammation (Chen et al., 2007). We wondered whether
pro-IL-1a might be released from necrotic AMs in response to
LPS. WT mice were given LPS or PBS (i.t.) and 2 hr later BALF
was collected and analyzed for the presence of IL-1a by immu-
noblotting. LPS-primed and ATP treated bone-marrow-derived
macrophages (BMDMs) were used as a positive control. We
found pro-IL-1a, but not mature IL-1a, in the BALF of LPS-
treated mice (Figure 1F). Next, we examined whether LPS could
induce AM necrosis. BAL cells were isolated 2 hr post LPS
and analyzed by flow cytometry for F4/80 (macrophages),
Annexin V, which detects apoptotic and necrotic cells, and
7AAD, which detects necrotic cells. Following LPS administra-
tion, AMs underwent increased necrotic cell death (Figure 1G).
These data suggested that IL-1b and NLRP3 inflammasome
are not required for the early development of LPS-induced ALI
but that pro-IL-1a might play an important role.
IL-1a Plays a Crucial Role in LPS-Induced Acute
Lung Injury
IL-1a can directly increase vascular endothelial cell permeability
in vitro and is speculated to be involved in acute vascular endo-
thelial injury associated with endotoxic shock (Royall et al.,
1989). To assess the possible direct involvement of IL-1a
in LPS-induced ALI, we administered LPS or PBS (i.t.) to WT
and Il1a/ mice, and 6 hr later BALF was collected and
analyzed. After LPS instillation, PMN recruitment and MPO
activity were significantly reduced in Il1a/ mice compared to
WT controls (Figures 2A and 2B). In addition, we blocked the
effects of IL-1a using an IL-1a neutralizing antibody. IL-1a
neutralization resulted in a significant reduction in PMN numbers
and MPO activity compared to animals receiving control anti-
body (Figures S1A and S1B). We next investigated vascular
leakage in the lung using Evans blue dye.Weobserved increased
Evans blue leakage from the vascular space into the lung paren-
chyma in LPS-treatedWTmice, which was dramatically reduced
in the lungs of Il1a/ mice. Quantitative analysis of Evans
blue extravasation into the lung tissue showed significantly
lower dye accumulation into the lungs of LPS treated Il1a/
mice compared to lungs of LPS-treated WT mice (Figure 2C),
suggesting that IL-1a plays a pivotal role in LPS-induced ALI.
As expected, IL-1a amounts were increased in BALF and lung
homogenates from WT mice, but not Il1a/ mice (Figure 2D).
Importantly, there was no significant difference in amounts of
TNF-a or KC in BALF and lung homogenate from Il1a/ mice
compared to WT mice after LPS treatment (Figures 2E and 2F).Immunity 42, 640–653, April 21, 2015 ª2015 Elsevier Inc. 641
Figure 1. LPS-Induced Acute Lung Injury Is
IL-1b Independent
(A) WT mice were i.t. administered PBS or LPS
(0.5 mg/kg) at time 0, and AM and PMN numbers
wereassessed inBALFbyflowcytometryover time.
(B–E) WT, Nlrp3/, and Casp1/ mice were i.t.
challenged with LPS for 6 hr as follows: (B) MPO in
lung homogenates, (C) IL-1b, (D) IL-1a, and (E) KC
concentrations were measured by ELISA.
(F and G) WT mice were i.t. administrated PBS
or LPS for 2 hr: (F) BALF was pooled (three mice)
and concentrated, and IL-1a protein concentra-
tions in BALF were checked by WB. Supernatant
and cell lysate of LPS (3 hr) primed BMDMs
treated with ATP (1 hr) was used as a positive
control. (G) BAL cells were probed with anti-F4/80
and stained with Annexin V and 7AAD. Necrotic
cells were measured by flow cytometry. Results
shown are representative of two experiments.
Five mice per group were used. Results are
shown as mean ± SD. ***p < 0.001.Macrophages are major producers of proinflammatory cyto-
kines in response to LPS, and TLR4 on hematopoietic cells
(but not stromal cells) is required for ALI following intratracheal
administration of LPS (Andonegui et al., 2009). To more specif-
ically assess the role of IL-1a, we generated hematopoietic
Il1a/ chimeric mice. IrradiatedWTmice received bone marrow
from IL-1a deficient or WT mice. After reconstitution (12 weeks),
the mice were given LPS or PBS (i.t.) and BALF was assessed
6 hr later. Mice that received Il1a deficient bone marrow showed
a significant reduction of IL-1a in BALF compared to WT trans-
plants (Figure 2G). This finding correlated with significantly
reduced PMN numbers and MPO activity in IL-1a deficient
bone marrow recipients compared to control mice receiving
WT bone marrow (Figures 2H and 2I). TNF-a concentrations642 Immunity 42, 640–653, April 21, 2015 ª2015 Elsevier Inc.in BALF were similar between both
groups (Figure 2J). Moreover significantly
increased PMN numbers, as well as
IL-1a concentrations, but not KC, were
observed in BALF from Il1a/ mice that
received WT bone marrow compared to
Il1a/ mice that received Il1a/ bone
marrow (Figures S1C–S1E). These find-
ings indicate that IL-1a released from
hematopoietic cells plays an important
role in LPS-induced ALI and neutrophil
infiltration.
We also confirmed the requirement
for MyD88 signaling in hematopoietic
cells by creating bone marrow chimeras.
WT mice received bone marrow from
Myd88/ mice, and control mice
received bone marrow from WT mice.
IL-1a and TNF-a amounts were dramati-
cally reduced in BALF from mice that
received Myd88/ bone marrow com-
pared with BALF from WT mice that
received WT bone marrow (Figures S1F
and S1G). As a control, we measuredRANTES (TLR4-TRIF pathway) (Tachado et al., 2010) and found
no difference in RANTES concentration in the BALF between
mice that received Myd88 deficient bone marrow and controls
(Figure S1H). These findings suggest that MyD88 signaling
in hematopoietic cells is required for the induction of key proin-
flammatory mediators in response to i.t. LPS.
IL-1a Signaling through Endothelial IL-1R Results
in Vascular Leakage
We investigated whether LPS-induced vascular permeability in
LPS-induced ALI occurred via a similar mechanism, except
using pro-IL-1a. We blocked IL-1 signaling in the LPS model
of ALI using the IL-1 receptor antagonist (IL-1RA). WT mice
were injected intravenously (i.v.) with IL-1RA or PBS every 3 hr
and LPS was administered (i.t.) 1.5 hr after first injection of
IL-1RA, followed 6 hr later by Evans blue injected i.v. and anal-
ysis 2 hr after that (Figure 3A). Inhibition of the IL-1 receptor
signaling in mice significantly attenuated Evans blue extravasa-
tion compared to control mice (Figure 3B).
Vascular endothelial (VE)-cadherin provides endothelial cell
barrier integrity (Xiao et al., 2003). Therefore, we measured
the amount of VE-cadherin on the surface of EC in lungs of
WT and Il1r/ after LPS administration. VE-cadherin staining
was significantly reduced in the lungs of WT mice compared
to Il1r/ mice 2 hr after i.t. instillation of LPS (Figure 3C),
suggesting that IL-1a might regulate vascular integrity through
endothelial IL-1R signaling during LPS-induced ALI. To assess
the role of endothelial IL-1R signaling in LPS induced neutrophil
recruitment, we generated chimeric mice between WT and
Il1r/ mice. WT mice received bone marrow from Il1r deficient
mice or Il1r/ mice received bone morrow from WT mice.
Mice that were deficient for IL-1R only on stromal cells had
a significant reduction in pulmonary PMN recruitment and
MPO activity (Figures 3D and 3E) compared to WT mice that
received Il1r/ bone marrow cells. However, no differences
were seen in KC concentrations (Figure 3F). These data
indicate that IL-1 signaling on stromal cells is required for
LPS-induced neutrophil recruitment. Additionally, after i.t.
administration of LPS, Il1r/ mice showed significantly fewer
PMNs in BALF and less MPO activity in the lungs compared
to WT mice (Figures S2A and S2B). We did not see any
difference in TNF-a, MIP-2, and KC protein amounts in BALF
and lung homogenate between WT and Il1r/ mice (Figures
S2C–S2E) suggesting that production of these cytokines
is downstream of LPS-TLR4 signaling and not IL-1-IL-1R during
LPS-induced ALI.
In order to assess a direct role for IL-1a in endothelial MyD88
signaling, we used a Cre loxP strategy to engineer EC-specific
MyD88-deficient mice (ECMyD88/). We crossed mice with the
MyD88fl allele (Hou et al., 2008) to mice carrying the Tie2-Cre
transgene, which is preferentially expressed in ECs (Kisanuki
et al., 2001). The deletion of the Myd88fl allele was assessed
by quantitative PCR (Figure S2F), andMyD88 protein expression
in aorta EC by Western blot (Figure S2G). Tie-2 has been re-
ported on a small number of hematopoietic stem cells in addition
to endothelium (Makinde and Agrawal, 2011), but Tie-2 is
turned off at the start of differentiation, making it unlikely that
nonendothelial cells would express it (De Palma et al., 2005).
Nevertheless, we generated chimeric mice by irradiating
ECMyD88/ or controlMyd88fl/flmice followed by transplantation
of WT bone marrow cells. After reconstitution (Figure S2H), the
mice were given i.t. recombinant IL-1a (rIL-1a) or PBS, and
1 hr later the lungs were lavaged and measured for the loss of
VE-cadherin on EC. Surface expression of VE-cadherin was
significantly reduced on EC from the lungs of LPS treated
WT/Myd88fl/fl mice compared to WT/ECMyD88/ mice
(Figure 3G). Collectively, these results suggest that pulmonary
endothelial MyD88, downstream of IL-1a signaling, plays
a crucial role in vascular permeability via downregulation or
internalization of VE-cadherin in vivo. Overall our data reveal a
critical role for IL-1R-MyD88 signaling in lung ECs in response
to i.t. LPS, and corroborates the role of IL-1a as the mediator
of LPS signaling on ECs.P2X7R Is Involved in Calcium Influx and Necrotic
Death of Alveolar Macrophages
While our data clearly show that LPS induced necrosis of AMs
leads to pro-IL-1a release and subsequent signaling on ECs to
allow neutrophil influx, the mechanism by which LPS induces
AM necrosis to initiate this cascade is still unclear. LPS can
initiate a rapid transient increase of cytosolic Ca2+ via calcium
release-activated calcium channels in bone-marrow-derived
dendritic cells (BMDC) (Matzner et al., 2008). LPS also leads to
ATP depletion in mouse lungs (Aggarwal et al., 2012), and ATP
depletion has been linked with necrotic cell death (Ha and
Snyder, 1999; Zong and Thompson, 2006). Thus, we investi-
gated whether i.t. LPSwould increase calcium influx and deplete
ATP in alveolar macrophages in this ALI model. AMs were iso-
lated from WT mice and loaded with Fluo-4 (calcium indicator).
Upon LPS stimulation, calcium mobilization was increased in
AMs with Ca2+-containing medium, but not AMs in Ca2+-free
medium (Figure S3A). Indeed, we observed that after LPS
instillation, intracellular ATP concentrations dropped in AMs
over time (Figure S3B), suggesting that LPS might deplete
intracellular ATP through increasing Ca2+ mobilization. It was
recently reported that TLR4 is not required for LPS-induced
Ca2+ mobilization in DCs (Zanoni et al., 2009). Similar to that
study, we also observed that Tlr4/ AMs responded to LPS
with Ca2+ mobilization (Figure S3C), indicating that a TLR4-
independent pathway is responsible for Ca2+ mobilization
after LPS. Finally, these data revealed that LPS-induced Ca2+
influx resulted in intracellular ATP depletion, as one possible
mechanism for the necrotic cell death of AMs.
Next we sought to understand the signaling mechanism for
LPS induced necrotic death of AMs. We focused on the puriner-
gic receptor P2X7 (P2X7R), which is expressed on most immune
cells, including AMs (Lemaire and Leduc, 2003) (Figure S3D), and
has gained recent notoriety due to its ability to induce calcium
mobilization (Garcia-Marcos et al., 2006). P2X7R also has a
potential binding site for bacterial LPS (Denlinger et al., 2001)
and was recently revealed to be important for LPS-induced
lung injury (Monc¸a˜o-Ribeiro et al., 2011). Therefore, we exam-
ined whether P2X7R was involved in LPS-induced Ca2+ mobility
and ATP depletion in AMs. AMs isolated from WT or P2x7r/
mice were loaded with the calcium indicator Fluo-4. After LPS
stimulation, calcium influx was increased in AMs from WT
mice, but not in AMs from P2x7r/ mice (Figure 4A). Moreover,
while LPS reduced ATP in AMs of both genotypes, ATP con-
centrations were significantly higher in AMs from P2x7r/
mice compared to WT controls after LPS (i.t.) administration
(Figure 4B). Consistent with this, P2X7R deficiency resulted in
less necrotic cell death (Figure 4C) and a significantly higher
number of surviving AMs compared to WT controls (Figure S3E),
which was associated with reduced leakage of pro-IL-1a into
the BALF compared to WT animals (Figure 4D). Importantly,
there was no difference in TNF-a concentration in the BALF of
both genotypes (Figure 4E). In addition, there was a significant
reduction of PMN number and MPO activity in the BALF and
lungs of P2x7r/ mice following (i.t.) LPS administration
(Figures 4F and 4G). Collectively, these data demonstrate
that the P2X7R plays an important role in LPS-induced ALI
by inducing Ca2+ mobilization, ATP depletion, necrosis, and
pro-IL-1a release in response to LPS.Immunity 42, 640–653, April 21, 2015 ª2015 Elsevier Inc. 643
Figure 2. IL-1a Is Crucial During LPS-Induced Acute Lung Injury
(A and B) WT and Il1a/mice were i.t. challenged with PBS or LPS, and 6 hr later (A) PMN numbers were counted in the BALF and (B) MPO concentrations were
measured in the lung homogenate.
(C) After 6 hr LPS i.t. administration, mice were injected (i.v.) with Evans blue dye and 2 hr later, Evans blue extravasation was measured by spectrophotometric
analysis.
(D–F) WT and Il1a/ mice were i.t. challenged with PBS or LPS and 6 hr later, (D) IL-1a, (E) TNF-a, and (F) KC concentrations were measured by ELISA.
(legend continued on next page)
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CD14 Is Required for P2X7R Dependent Ca2+
Mobilization by LPS
A recent report suggested that LPS does not induce P2X7R-
related activity in P2X7R expressing HEK293 cells (Leiva-
Salcedo et al., 2011). Therefore, we tested whether LPS directly
binds to P2X7R. Empty vector (EV) or P2X7R stably-expressing
HEK293 cells were stimulated with LPS-Alexa 594 for 10 min
and fixed cells were stained with anti-HA for P2X7R. However,
we observed extremely weak co-localization between LPS and
P2X7R (Figure 5A, upper panel) in P2X7R stably-expressing
HEK293 cells. According to the literature, the LPS binding site
on P2X7R is located within the cytoplasmic C-terminal tail of
P2X7R (Denlinger et al., 2001). Therefore, we hypothesized that
LPS uptake might be important for LPS binding to P2X7R. Previ-
ous studies revealed that CD14 plays an active role during LPS
internalization (Kitchens and Munford, 1998; Kitchens et al.,
1998). In a recent study, CD14 was also found to be required
for LPS induced Ca2+ influx in BMDCs (Zanoni et al., 2009).
For this reason, EV or P2X7R stably-expressing HEK293 cells
were transfected with CD14, stimulated with LPS-Alexa 594,
and stained with anti-HA for the C-terminal tail of P2X7R. Con-
sistent with the hypothesis, CD14 transfection internalized LPS,
which resulted in strong colocalization between LPS and
P2X7R in P2X7R and CD14 stably-expressing cells (Figure 5A,
lower panel). Moreover, LPS increased Ca2+ influx only in
P2X7R and CD14-expressing HEK293 cells (Figure 5B, and
Movies S1, S2, S3, and S4), suggesting that CD14 might be
important for LPS-induced channel activity of P2X7R by inter-
nalizing LPS. CD14 is known as a coreceptor for TLR4 and is
important for its downstream signaling by LPS (Wright et al.,
1990). However, CD14 is not required for TLR4-MyD88 depen-
dent signaling when stimulated with a high dose of LPS
(Jiang et al., 2005; Zanoni et al., 2009) (Figure S4A). Next, we
tested whether CD14 is required for LPS-induced Ca2+ influx
and necrotic death of AMs by using CD14 antibody in ex vivo
and in vivo models. CD14 neutralizing antibody completely in-
hibited LPS induced Ca2+ mobilization in mouse AMs compared
to control antibody (Figure 5C). In vivo, WT mice were given i.t.
anti-CD14 antibody (10mg/mouse) or control antibody 1 hr before
i.t. LPS instillation. CD14 neutralization significantly reduced
necrotic death of AMs and IL-1a concentrations in BALF
compared to control mice (Figures 5D and 5E). Importantly,
TNF-a concentrations in BALF were comparable between these
two groups (Figure 5F). Additionally, CD14 was expressed
equally in both AMs of WT and P2x7r/ mice (Figure S4B).
Collectively, these data indicate that CD14 plays an important
role in LPS-inducedCa2+mobilization and necrotic death of AMs.
CD14 Interacts with P2X7R
We and others have shown that LPS is internalized into cells
by a CD14-dependent pathway. Therefore, we hypothesized
that CD14 facilitated LPS internalization where it could bind to
P2X7R. CD14 and P2X7R expression were not altered after
LPS stimulation in CD14 or P2X7R stably-expressing HEK293(G–J) WT mice received bone marrow cells fromWT or Il1a/mice, and 12 week
in BALF by ELISA. (H) PMN numbers were counted in the BALF. (I) MPO a
BALF were determined by ELISA. Results shown are representative of two expe
Figure S1.cells. However, CD14 and P2X7R amounts were time-depen-
dently reduced after LPS stimulation in P2X7R and CD14
stably expressing cells (Figure 6A), suggesting that the LPS-
CD14-P2X7R receptor complex might be rapidly degraded by
a negative regulatory mechanism.
CD14 is located within lipid rafts of the plasma membrane
following LPS stimulation (Olsson and Sundler, 2006; Triantafilou
et al., 2002). P2X7R is distributed among both raft and nonraft
domains of the plasma membrane (Garcia-Marcos et al.,
2006). Therefore, we carried out coimmunoprecipitiation exper-
iments for interactions between CD14 and P2X7R. CD14 and
P2X7R-HA were immunoprecipitated with anti-CD14 or anti-
HA antibody from P2X7R and CD14 stably expressing HEK293
cells stimulated with or without LPS for 10 min. In the absence
of LPS, CD14 weakly interacted with P2X7R, whereas strong
interaction between those two receptors was seen after LPS
stimulation (Figure 6B). Additionally, we looked for colocalization
of CD14 and P2X7R by confocal microscopy. Similar to the
coprecipitation findings, colocalization of CD14 and P2X7R
was increased after LPS stimulation compared to PBS control
(Figure 6C), suggesting that CD14 is a coreceptor for P2X7R.
In conclusion, we have identified a mechanism by which IL-1a
participates in LPS-induced early neutrophil recruitment to the
lungs and increased pulmonary vascular permeability during
ALI, through the release of pro-IL-1a from necrotic AMs via
a CD14-P2X7R-dependent pathway. The downregulation of
VE-cadherin on endothelial tight junctions follows in response
to pro-IL-1a in an IL-1R-MyD88-dependent fashion. These data
establish IL-1a as a critical initiator of neutrophil recruitment and
inflammatory responses during LPS induced acute lung injury.
DISCUSSION
It is well documented that both IL-1b and IL-1a can be processed
by NLRP3-Caspase-1 (Gross et al., 2012) and are important
regulators for neutrophil recruitment into the lung during inflam-
mation. Therefore, we hypothesized that dying AM release IL-1
via the NLRP3 inflammasome. However, both Nlrp3- and
Caspase-1-deficient mice had similar amounts of neutrophil
recruitment as WT mice and no IL-1b secretion at the early time
points investigated. IL-1a amounts were elevated in BALF after
i.t. LPS administration despite the lack of Caspase-1 or NLRP3.
In contrast to IL-1b, IL-1a has been considered an endogenous
danger signal, functioning as an alarmin. Uncleaved IL-1a can
be passively released upon necrotic cell death, triggering neutro-
philic sterile inflammation (Chen et al., 2007; Rider et al., 2011).
This form of IL-1a is capable of binding to IL-1R1 and is biologi-
cally active (Mosley et al., 1987). In our study, we detected only
pro-IL-1a in the BALF of LPS-treated mice, and our data reveal
that pro-IL-1a released from necrotic AMs is the main driver of
the early inflammation in LPS-induced ALI.
IL-1a deficiency significantly reduced neutrophil recruitment
after i.t. administration of LPS. Our results revealed that IL-1a,
not IL-1b, is required for early events of LPS-induced ALI.s later mice were i.t. challenged with PBS or LPS 6 hr. (G) IL-1a concentrations
ctivity was measured in the lung homogenate. (J) TNF-a amounts in the
riments. Results are shown as mean ± SD. **p < 0.01, ***p < 0.001. See also
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Figure 3. IL-1R-MyD88 in Endothelial Cells Is Important for Vascular Permeability
(A) WT mice were i.v. injected with PBS or IL-1RA following indicated scheme.
(B) Evans blue dye was i.v. injected 2 hr before termination of the experiment and Evans blue extravasation was assessed by spectrophotometric analysis.
(legend continued on next page)
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However, because we saw constitutive expression of pro-IL-1a
in lung homogenates, and because others show that lung
endothelial cells can also constitutively express pro-IL-1a (Brunn
et al., 2008), we created bone marrow chimeric mice (WT mice
with Il1a/ bone marrow, and Il1a/ mice with WT bone
marrow) to determine which cells are responsible for pro-IL-1a
production in response to i.t. LPS instillation. We found that
mice with Il1a/ hematopoietic cells had significantly reduced
pro-IL-1a production consistent with our hypothesis that pro-
IL-1a is generated by AMs in response to LPS in this ALI model.
In contrast to our model, Noulin et al. finds that IL-1R-deficient
mice display normal neutrophil recruitment in the lungs of mice
given LPS intranasally (Noulin et al., 2005). However, in their
study, they give substantially more LPS (50 mg compared to
10 mg) and made observations at later time points (24 hr versus
8 hr). In contrast to their study, IL-1 receptor antagonist is
required to prevent deleterious inflammation during a Klebsiella
pneumoniae infection (Herold et al., 2011). Moreover, Tanabe
et al. find that Il1a/ Il1b/ double knockout mice have
increased amounts of TNF-a, thereby compensating for the
loss of IL-1 signaling during K. pneumoniae infection (Tanabe
et al., 2005).
Endothelium must be activated either directly by LPS or
indirectly by mediators released by other cells to become more
permeable and express adhesion molecules, facilitating PMN
transmigration into tissues. Because ECs express TLR4, as
well as receptors for TNF-a and IL-1, either scenario was thought
to be plausible. However, while endothelial TLR4 is able to
recognize and respond to systemically administered LPS, it is
unable to induce neutrophil migration into the lungs when LPS
is given locally by intratracheal installation (Andonegui et al.,
2009). Both IL-1a and IL-1b can trigger the MyD88 signaling
cascade in endothelial cells and break down endothelial cell
junctions (Royall et al., 1989; Zhu et al., 2012). Indeed, our
current data demonstrated that AMs respond directly to LPS,
undergo necrosis, and release pro-IL-1a, which then acts on
lung vascular endothelium triggering the IL-1R-MyD88 signaling
pathway to downregulate VE-cadherin, resulting in increased
vascular permeability and neutrophil infiltration. Although it is
always possible that ex vivo handling of macrophages in the
BALF might result in them dying more easily before flow cyto-
metric analysis, we believe that this is highly unlikely because
this process is extremely quick (1 hr), and our PBS control
group did not show any macrophage necrosis.
Although our data indicated that necrotic death of AMs led to
the release of pro-IL-1a and its subsequent downstream effects,
the mechanism for the induction of necrosis by LPS was not
understood. LPS can induce Ca2+ mobilization in BMDCs
(Matzner et al., 2008; Zanoni et al., 2009), but there are conflict-
ing results for LPS-induced Ca2+ mobilization in macrophages(C) WT and Il1r/ mice were challenged with PBS or LPS 2 hr, lung single cell
cytometry.
(D–F) WT mice received bone marrow cells from Il1r/ mice or Il1r/ mice re
challenged with PBS or LPS 6 hr. (D) PMN numbers counted in the BALF, (E) MP
BALF were measured by ELISA.
(G)Myd88fl/fl or ECMyD88/ mice received bone marrow cells from WT mice and
1 hr, lung single cell suspensions were obtained and VE-cadherin was measure
Results are shown as mean ± SD. **p < 0.01, ***p < 0.001. See also Figure S2.(Seabra et al., 1998; Zanoni and Granucci, 2010; Zhou et al.,
2006). However, given the similarities between AM and DCs,
we hypothesized that LPS could induce Ca2+ influx to trigger
necrotic death of AM. Increased intracellular Ca2+ can affect
mitochondrial inner membrane integrity, abrogating ATP syn-
thesis and even triggering ATP hydrolysis by mitochondria
(Brookes et al., 2004), eventually culminating in necrosis
(Proskuryakov et al., 2003).
In ex vivo experiments, LPS-induced Ca2+ mobilization is
TLR4-independent in AM, as well as in BMDCs (Zanoni et al.,
2009). Therefore, we focused on P2X7R, a purinergic receptor
that contains multiple protein and lipid interaction motifs,
including a potential binding site for bacterial LPS (Denlinger
et al., 2001), and plays an essential role for LPS-induced acute
lung injury (Monc¸a˜o-Ribeiro et al., 2011). P2X7R is thought to
act as a trigger for cell necrosis (Jun et al., 2007) and AM express
functional P2X7 receptors, which are required for ATP-induced
Ca2+ mobilization (Lemaire and Leduc, 2003; Myrtek et al.,
2008). Therefore, we examined whether P2X7R was involved in
LPS-induced necrotic death of AM. Indeed, we found greater
amounts of ATP in AM of P2X7R-deficient mice compared to
WT mice. This was associated with less necrotic cell death and
reduced pro-IL-1a secretion into the BALF. However, LPS alone
is unable to induce any P2X7R-related activity, suggesting that
the P2X7R is not directly activated by endotoxin in vitro (Leiva-
Salcedo et al., 2011). In our in vitro experiments, we also
detected only weak fluorescence for LPS-Alexa 594 in P2X7R-
expressing HEK293 cells, and we did not see any Ca2+ mobiliza-
tion in response to LPS in those cells. However, because the
LPS binding site of P2X7R is located in its C-terminal cytosolic
tail (Denlinger et al., 2001), we hypothesized that LPS might
require internalization for LPS binding to P2X7R. We focused
on CD14 because it is required for LPS uptake (Kitchens and
Munford, 1998) and plays a role in LPS-induced Ca2+ mobiliza-
tion in BMDC (Zanoni et al., 2009). For this reason, we made
P2X7R and CD14 stably-expressing HEK293 cells to address
whether CD14 is important for P2X7R-dependent Ca2+ mobiliza-
tion by LPS. Our data suggested that LPS was internalized in a
CD14-dependent manner and bound to P2X7R, which led to
Ca2+ mobilization in CD14 and P2X7R stably-expressing
HEK293 cells. This was confirmed by the fact that CD14 neutral-
ization significantly blocked LPS-induced Ca2+ mobilization in
AM. Moreover, CD14 blockade significantly reduced necrotic
death of AM and pro-IL-1a secretion into the BALF without
altering TNF-a. In a similar vein, CD14 interacts with TLR7 and
TLR9 ligands, facilitating their uptake, and serving as a corecep-
tor required for proper activation (Baumann et al., 2010). We also
found that CD14 interacts with P2X7R following LPS stimulation,
suggesting that CD14 might act as a coreceptor for P2X7R,
as well as other TLRs.suspensions were obtained, and surface VE-cadherin was measured by flow
ceived bone marrow cells from WT mice, and 12 weeks later mice were i.t.
O activity was measured in the lung homogenate, and (F) KC concentrations in
12 weeks later mice were i.t. challenged with recombinant IL-1a (rIL-1a). After
d by flow cytometry. Results shown are representative of three experiments.
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Figure 4. P2X7 Receptor Is Crucial for LPS-induced ATP Depletion and Necrosis in Alveolar Macrophages
(A) AM from WT or P2x7r/ mice were loaded with Fluo-4 a calcium indicator (4 mM) for 30 min at room temperature and calcium mobility was measured by
confocal microscopy.
(B and C) WT and P2x7r/mice were i.t. challenged with PBS or LPS 30min (B) or 2 hr (C). (B) ATP amounts in the AMs were measured by ATP assay kit. (C) BAL
cells were probed F4/80 and stained with Annexin V and 7AAD and necrotic cells were measured by flow cytometry.
(D–G)WT and P2x7r/mice were i.t. challenged with or without LPS 4 hr. (D) IL-1a and (E) TNF-a concentrations in the BALFwere determined by ELISA. (F) PMN
numbers in the BALF and (G) MPO activity were measured in the lung homogenate. Results shown are representative of two experiments. Results are shown
as mean ± SD. **p < 0.01, ***p < 0.001. See also Figure S3.
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Figure 5. CD14 Is Required for LPS-P2X7R Dependent Calcium Influx
(A) HEK293 cells were stimulated with LPS-Alexa594 (2.5 mg/ml) for 10 min and probed for P2X7R (anti-HA) and followed by Alexa 488 (green) conjugated
anti-rabbit secondary antibody. LPS (red) and P2X7R (green) localizationweremeasured by fluorescencemicroscopy. Nuclei are counterstainedwith DAPI (blue).
(B) EV, CD14, P2X7R, and P2X7R and CD14 stably expressing HEK293 cells were loaded with Fluo-4 (4 mM) for 30 min and calcium mobility was measured
by confocal microscopy.
(legend continued on next page)
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Figure 6. CD14 Interacts with P2X7R
(A) CD14 and P2X7R expression was detected by
WB at various time points after LPS stimulation.
(B and C) P2X7R and CD14 stably expressing
HEK293 cells were stimulated with PBS or LPS for
10 min. CD14 and P2X7R was immunoprecipitated
fromwhole cell extracts using anti-CD14 or anti-HA
(for P2X7R) antibodies and antibodies+beads
served as negative control. (C) P2X7R and CD14
stably expressing HEK293 cells were fixed and
incubated with anti-CD14 and anti-HA (for P2X7R)
antibodies for fluorescence microscopy. Nuclei are
counterstained with DAPI (blue). Scale bar repre-
sents 10 mm.In summary, our data reveal an unappreciated and key role for
IL-1a in the complex cascade of events that are triggered upon
exposure of the airways to LPS, leading to neutrophil recruitment
to the lungs as an early response during ALI and ARDS. LPS
provides a dual signal on alveolar macrophages that induces
cytokine production (TLR4-MyD88) and necrosis (P2X7R-
CD14) that results in the release of pro-IL-1a, which subse-
quently activates endothelial cells (IL-1R-MyD88), inducing tight
junction opening to allow neutrophils to infiltrate into the lungs.
Understanding the complex and sequential molecular mecha-
nisms by which immune cells are recruited to the lungs in
response to LPS or bacteria remains an important goal and
might provide potential novel targets to modulate immune re-
sponses and treat ALI and ARDS.EXPERIMENTAL PROCEDURES
Mice
Myd88fl/fl mice were obtained from Dr. Anthony DeFranco (University of
California). Casp1/ mice (Kuida et al., 1995) and TekCre mice (Tie2-Cre)
were kindly provided by Dr. Richard Flavell (Yale University). Nlrp3/ mice
(Mariathasan et al., 2006) were generously provided by Dr. Katherine Fitzger-
ald (University of Massachusetts Medical School, Worcester). Il1a/ mice
were kindly provided by Dr. Yoichiro Iwakura (University of Tokyo). C57BL/6,
Tlr4/, P2rx7/ (P2X7 receptor) mice were obtained from Jackson Labora-
tories. Myd88/ mice (Naiki et al., 2005) were maintained according to
Cedars-Sinai Medical Center Institutional Animal Care and Use Committee
guidelines. All mice were used at 8–9 weeks of age.(C) AM from WT mice were incubated with anti-mouse CD14 antibody 2 hr and loaded with Fluo-4 (4 mM
microscopy.
(D–F) WT mice were i.t. treated with control or anti-mouse CD14 antibody (1 hr) prior to LPS challenge 2 hr. (
and necrotic cells were measured by flow cytometry. (E) IL-1a and (F) TNF-a concentration in the BALF we
sentative of two experiments. Results are shown as mean ± SD. *p < 0.05. Scale bar represents 10 mm. Se
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Alveolar macrophages were cultured on glass cov-
erslips and loaded with 4 mM of Fluo-4 AM and
equal volume Pluronic F-127 (Invitrogen) in HBSS
for 30 min at room temperature then were washed
two times in PBS containing 2% FBS, 1 mM sulfin-
pyrazone (Santa Cruz), and RPMI (2% FBS) was
added. For HEK293, cells were cultured in com-
plete DMEM on the glass coverslip coated with
collagen type I (BD Biosciences) overnight and
then loaded with 4 mM of Fluo-4 in serum-free
DMEM for 30 min at 37C. This was followed by
one wash with PBS and then cells were cultured in DMEM (2% FBS) for
20 min at 37C. The fluorescence of Fluo-4 was measured by using confocal
laser scanning microscopy (Leica Mycrosystems).
Detection of Intracellular ATP
The ATP concentrations in total BAL cells (AM) were determined with the
ATPlite luminescence assay kit from PerkinElmer according to the manufac-
turer’s instructions. BAL cells were assayed at various time points after intra-
tracheal LPS administration.
Immunoprecipitation
CD14 and P2X7R-HA stably expressingHEK293 (23 106) cells were lysedwith
a buffer containing HEPES (pH 7.4), 150mMNaCl, 10% glycerol, 0.5%NP-40,
1 mM Na3VO4, and protease inhibitor (Sigma) for 30 min and whole-cell ex-
tracts were pre-cleaned by using anti-mouse or anti-rabbit beads (Rockland,
TrueBlot) for 30 min at 4C. After centrifugation at 3,0003 rpm for 5 min at
4C, CD14, or P2X7R was immunoprecipitated overnight by using 5 mg of
mouse anti-hCD14 (R&D) or rabbit anti-HA (Cell Signaling) followed by addition
with anti-mouse or anti-rabbit beads for 1 hr on rocking platform at 4C. The
fractions were then subjected to SDS-PAGE, and immunoblotting was
performed with anti-hCD14 and anti-HA antibodies according to standard
procedures.
Immunocytochemistry
HEK293 cells were cultured on glass coverslips coated with collagen type I
(BD Biosciences) overnight. LPS-594 or LPS was diluted in complete DMEM
medium for 15 min at 37C. After stimulation with LPS (2.5 mg/ml) for 10 min,
HEK293 cells were fixed and incubated with anti-HA and anti-CD14 antibodies
for 2 hr at room temperature. Followed by Alexa 488 and Alexa 594 secondary) and calcium mobility was measured by confocal
D) BAL cells were stained with Annexin V and 7AAD
re determined by ELISA. Results shown are repre-
e also Figure S4 and Movies S1-4.
antibodies, localization was measured by fluorescence microscopy with BZ-II
analyzer (KEYENCE).
Transfection
HEK293 cells were cultured with DMEM complete medium (CORNING cellgro)
and transfected with pLenti-GIII-CMV-hP2RX7-HA (Applied Biological Mate-
rials) or pcDNA3-hCD14 (Addgene) by using Lipofectamine 2000 (Invitrogen).
The cells were positively selected by 1 mg/ml of G418 (Gemini Bio-Products)
and 5 mg/ml of Puromycin (InvivoGen). For co-expressing cells, hP2X7R stably
expressing HEK293 cells were transfected with pcDNA3-hCD14 and selected
with G418.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, Supplemental Experimental
Procedures, and four movies and can be found with this article online at
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